We recently published a list of 10 Worst Booming Stocks to Buy According to Short Sellers. In this article, we are going to ...
Eli Lilly surged 58% in 2024, driven by weight-loss drugs and strong earnings. The technical chart shows consolidation. See ...
Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...
Despite the current downward trend of Novo Nordisk, it is an excellent stock to buy for long-term gains, driven by the ...
Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...
FedEx cut its outlook after posting lower quarterly profit and revenue. Its stock fell 13%; shares of rival UPS also fell. Ford and General Motors fell after Mercedes-Benz trimmed its forecasts and ...
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...
However, after its phase 1 success with TERN-601, it will raise more money by taking advantage of its soaring stock price and ...
This week, the FDA approved J&J’s JNJ Tremfya for treating an inflammatory bowel disease condition (“IBD”), ulcerative ...
Large drug-maker stocks have witnessed a strong run this year, driven by positive pipeline news and regulatory approvals. The FDA has granted approval to 29 novel drugs this year. Innovation in the ...
He is a Chartered Market Technician (CMT). A small-cap stock is a company with a market capitalization between $250 million to $2 billion. The precise figures used can vary among different ...